Skip to main content

Find Clinical Trials

Home
Conditions
Thoracic Neoplasms

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,134 public trials 1,863 recruiting studies

Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Completed

AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors

NCT02511795

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations: Research Site Denver, Colorado, United States

Research Site Sarasota, Florida, United States

Research Site New York, United States

Research Site Nashville, Tennessee, United States

View Trial Details

Completed

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

NCT02639091

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +10 more
Locations: Chicago, Illinois, United States

Bethesda, Maryland, United States

Detroit, Michigan, United States

Charleston, South Carolina, United States

View Trial Details

Completed

Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens

NCT01648166

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: University of Kentucky Lexington, Kentucky, United States

View Trial Details

Completed

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

NCT00547651

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States

Arizona Oncology Associates Tucson, Arizona, United States

Little Rock Hematology Oncology Associates Little Rock, Arkansas, United States

Cancer Care Associates of Fresno Medical Group, Inc. Fresno, California, United States

View all 140 locations

View Trial Details

Completed

BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology

NCT01660776

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +26 more
Locations: Rennes EFS Rennes, Brittanny, France

Rennes University Hospital Rennes, Brittanny, France

Institut Paoli Calmette Marseille, France

Montpellier University Hospital Montpellier, France

View Trial Details

Completed

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

NCT01631357

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +14 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Completed

Effect on Patient Reported Outcomes of VATS and SABR (LILAC)

NCT02882750

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Not specified

View Trial Details

Completed

LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer

NCT00005858

Conditions: Adnexal Diseases, Bladder Cancer, Breast Cancer, +52 more
Locations: Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2

NCT02867371

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Duke University Durham, North Carolina, United States

Cancer Treatment Centers of America at Southwestern Regional Medical Center Tulsa, Oklahoma, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer

NCT02000947

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Tucson, Arizona, United States

Research Site Los Angeles, California, United States

Research Site Los Angeles, California, United States

View all 69 locations

View Trial Details